Picture of Stratec SE logo

SBS Stratec SE Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Momentum

Relative Strength (%)
1m-5.87%
3m-7.31%
6m-15.88%
1yr-44.18%
Volume Change (%)
10d/3m-19.97%
Price vs... (%)
52w High-38.19%
50d MA-0.52%
200d MA-8.69%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)20.31
PEG Ratio (f)0.72
EPS Growth (f)39.17%
Dividend Yield (f)2.34%
Valuation (ttm)IndustryMarket
Price to Book Value2.3
Price to Tang. Book4.87
Price to Free Cashflown/a
Price to Sales2.04
EV to EBITDA17.89

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.5%
Return on Equity5.46%
Operating Margin7.46%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue€m187.82214.16250.1287.33274.63268.382845.77%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-61.66+58.37+66.78+43.33-28.42-37.14+39.17n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Stratec SE EPS forecast chart

Profile Summary

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
November 27th, 2018
Public Since
August 25th, 1998
No. of Employees
1,532
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
12,155,942
Blurred out image of a map
Address
Gewerbestr. 37, BIRKENFELD, 75217
Web
https://www.stratec.com/
Phone
+49 708279160
Contact
Jan Keppeler
Auditors
EBNER STOLZ GMBH & CO. KG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT ST

SBS Share Price Performance

Upcoming Events for SBS

Full Year 2023 Stratec SE Earnings Release

Stratec SE METZLER Small Cap Days

Q1 2024 Stratec SE Earnings Release

Q1 2024 Stratec SE Earnings Call

Stratec SE at UBS Pan European Small and Mid-Cap Conference

Stratec SE at Berenberg Diagnostics Conference

Stratec SE Annual Shareholders Meeting

Stratec SE Annual Shareholders Meeting

Dividend For SBSG.DE - 0.5500 EUR

Stratec SE at Warburg Highlights Conference

Half Year 2024 Stratec SE Earnings Release

FAQ